|
1
|
Couzin J: Breast cancer. Dissecting a
hidden breast cancer risk. Science. 309:1664–1666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ursin G, Ma H, Wu AH, Bernstein L, Salane
M, Parisky YR, Astrahan M, Siozon CC and Pike MC: Mammographic
density and breast cancer in three ethnic groups. Cancer Epidemiol
Biomarkers Prev. 12:332–338. 2003.PubMed/NCBI
|
|
3
|
Maskarinec G, Pagano I, Lurie G, Wilkens
LR and Kolonel LN: Mammographic density and breast cancer risk: The
multiethnic cohort study. Am J Epidemiol. 162:743–752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Diorio C, Pollak M, Byrne C, Mâsse B,
Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C and Brisson J:
Insulin-like growth factor-I, IGF-binding protein-3, and
mammographic breast density. Cancer Epidemiol Biomarkers Prev.
14:1065–1073. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bremnes Y, Ursin G, Bjurstam N, Rinaldi S,
Kaaks R and Gram IT: Insulin-like growth factor and mammographic
density in postmenopausal Norwegian women. Cancer Epidemiol
Biomarkers Prev. 16:57–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grimberg A and Cohen P: Role of
insulin-like growth factors and their binding proteins in growth
control and carcinogenesis. J Cell Physiol. 183:1–9. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo YP, Martin LJ, Hanna W, Banerjee D,
Miller N, Fishell E, Khokha R and Boyd NF: Growth factors and
stromal matrix proteins associated with mammographic densities.
Cancer Epidemiol Biomarkers Prev. 10:243–248. 2001.PubMed/NCBI
|
|
8
|
Sarfstein R, Maor S, Reizner N,
Abramovitch S and Werner H: Transcriptional regulation of the
insulin-like growth factor-I receptor gene in breast cancer. Mol
Cell Endocrinol. 252:241–246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller BS and Yee D: Type I insulin-like
growth factor receptor as a therapeutic target in cancer. Cancer
Res. 65:10123–10127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hartog H, Wesseling J, Boezen HM and van
der Graaf WT: The insulin-like growth factor 1 receptor in cancer:
Old focus, new future. Eur J Cancer. 43:1895–1904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Happerfield LC, Miles DW, Barnes DM,
Thomsen LL, Smith P and Hanby A: The localization of the
insulin-like growth factor receptor 1 (IGFR-1) in benign and
malignant breast tissue. J Pathol. 183:412–417. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhargava R, Beriwal S, McManus K and Dabbs
DJ: Insulin-like growth factor receptor-1 (IGF-1R) expression in
normal breast, proliferative breast lesions, and breast carcinoma.
Appl Immunohistochem Mol Morphol. 19:218–225. 2011.PubMed/NCBI
|
|
13
|
Ouban A, Muraca P, Yeatman T and Coppola
D: Expression and distribution of insulin-like growth factor-1
receptor in human carcinomas. Hum Pathol. 34:803–808. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yanochko GM and Eckhart W: Type I
insulin-like growth factor receptor over-expression induces
proliferation and anti-apoptotic signaling in a three-dimensional
culture model of breast epithelial cells. Breast Cancer Res.
8:R182006. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimizu C, Hasegawa T, Tani Y, Takahashi
F, Takeuchi M, Watanabe T, Ando M, Katsumata N and Fujiwara Y:
Expression of insulin-like growth factor 1 receptor in primary
breast cancer: Immunohistochemical analysis. Hum Pathol.
35:1537–1542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chong YM, Williams SL, Elkak A, Sharma AK
and Mokbel K: Insulin-like growth factor 1 (IGF-1) and its receptor
mRNA levels in breast cancer and adjacent non-neoplastic tissue.
Anticancer Res. 26:167–173. 2006.PubMed/NCBI
|
|
17
|
Kim JH, Cho YH, Park YL, Sohn JH and Kim
HS: Prognostic significance of insulin growth factor-I receptor and
insulin growth factor binding protein-3 expression in primary
breast cancer. Oncol Rep. 23:989–995. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Creighton CJ, Casa A, Lazard Z, Huang S,
Tsimelzon A, Hilsenbeck SG, Osborne CK and Lee AV: Insulin-like
growth factor-I activates gene transcription programs strongly
associated with poor breast cancer prognosis. J Clin Oncol.
26:4078–4085. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bock K, Hadji P, Duda VF, Jackisch C and
Wagner U: Mammographic breast density and breast cancer risk during
HRT. Zentralbl Gynakol. 127:217–221. 2005.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin LJ, Minkin S and Boyd NF: Hormone
therapy, mammographic density, and breast cancer risk. Maturitas.
64:20–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding J, Warren R, Girling A, Thompson D
and Easton D: Mammographic density, estrogen receptor status and
other breast cancer tumor characteristics. Breast J. 16:279–289.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghosh K, Brandt KR, Sellers TA, Reynolds
C, Scott CG, Maloney SD, Carston MJ, Pankratz VS and Vachon CM:
Association of mammographic density with the pathology of
subsequent breast cancer among postmenopausal women. Cancer
Epidemiol Biomarkers Prev. 17:872–879. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Harvey JA and Bovbjerg VE: Quantitative
assessment of mammographic breast density: Relationship with breast
cancer risk. Radiology. 230:29–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li T, Sun L, Miller N, Nicklee T, Woo J,
Hulse-Smith L, Tsao MS, Khokha R, Martin L and Boyd N: The
association of measured breast tissue characteristics with
mammographic density and other risk factors for breast cancer.
Cancer Epidemiol Biomarkers Prev. 14:343–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pollak M: IGF-I physiology and breast
cancer. Recent Results Cancer Res. 152:63–70. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meggiorini ML, Labi L, Vestri AR, Porfiri
LM, Savelli S and De Felice C: Tamoxifen in women with breast
cancer and mammographic density. Eur J Gynaecol Oncol. 29:598–601.
2008.PubMed/NCBI
|
|
27
|
Pinheiro SP, Holmes MD, Pollak MN,
Barbieri RL and Hankinson SE: Racial differences in premenopausal
endogenous hormones. Cancer Epidemiol Biomarkers Prev.
14:2147–2153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kalla Singh S, Tan QW, Brito C, De León M
and De León D: Insulin-like growth factors I and II receptors in
the breast cancer survival disparity among African-American women.
Growth Horm IGF Res. 20:245–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rozengurt E, Sinnett-Smith J and Kisfalvi
K: Crosstalk between insulin/insulin-like growth factor-1 receptors
and G protein-coupled receptor signaling systems: A novel target
for the antidiabetic drug metformin in pancreatic cancer. Clin
Cancer Res. 16:2505–2511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nahta R, Yuan LX, Zhang B, Kobayashi R and
Esteva FJ: Insulin-like growth factor-I receptor/human epidermal
growth factor receptor 2 heterodimerization contributes to
trastuzumab resistance of breast cancer cells. Cancer Res.
65:11118–11128. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chong K, Subramanian A, Sharma A and
Mokbel K: Measuring IGF-1, ER-α and EGFR expression can predict
tamoxifen-resistance in ER-positive breast cancer. Anticancer Res.
31:23–32. 2011.PubMed/NCBI
|
|
32
|
Taunk NK, Goyal S, Moran MS, Yang Q,
Parikh R and Haffty BG: Prognostic significance of IGF-1R
expression in patients treated with breast-conserving surgery and
radiation therapy. Radiother Oncol. 96:204–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kostopoulos I, Arapantoni-Dadioti P, Gogas
H, et al: Evaluation of the prognostic value of HER-2 and VEGF in
breast cancer patients participating in a randomized study with
dose-dense sequential adjuvant chemotherapy. Breast Cancer Res
Treat. 96:251–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
